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ABSTRACT 
Pituitary homeobox 3 (Pitx3) is a transcription factor that is involved with ocular 
development.  Knockout of the Pitx3 gene in mice results in defects in the lens.  We have 
developed Pitx3 knockout in porcines as a model system to assess the effects of blastocyst 
complements with human umbilical cord blood stem cells (hUCBSC) and human induced 
pluripotent stem cells (hiPSC).  TALENS were used to knockout (KO) Pitx3 in porcine 
fibroblasts.  DNA from KO fibroblasts were transferred to enucleated porcine oocytes to 
generate KO blastocysts.  KO blastocysts and KO blastocysts with injections of hUCBSC 
or hiPSCs were transferred to surrogate pigs and allowed to develop to 62 days in gestation 
for comparisons with wild type (WT) porcine fetuses at the same gestational age.  WT 
fetuses exhibited well-formed lenses.  In contrast, the lenses in Pitx3 KO fetuses were mal-
formed and poorly developed.    Complementation with hiPSCs or hUCBSC did not rescue 
the KO lens phenotype.  These results demonstrate that Pitx3 KO in porcine results in 
arrested lens development similar to that observed in mice.  Lens complementation with 
hiPSC and hUCBSC, however, was not successful, possibly due to poor contribution of 
“non-ground state” or ‘primed’ human stem cells to the developing porcine fetus.     
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INTRODUCTION 
 
  In the past decade the field of stem cell biology and regenerative medicine has grown with 
leaps and bounds. The extensive capacity of self-renewal and potency of pluripotent stem 
cells has led to various cell replacement therapies, tissue engineering and regenerative 
medicine. Current strategies of organ transplantation are limited by problems such as lack 
of donors, HLA type matching, immune rejection and graft versus host disease, etc. 
(Choumerianou et al., 2008). Thus, new strategies for the development of donor-derived 
organs are underway and stem cells contribute greatly as therapeutic tools against many 
degenerative diseases, not limited to, Parkinson’s Disease (PD), Alzheimer’s Disease 
(AD), stroke, Huntington’s disease, muscular dystrophy, and anterior segment macular 
dysgenesis (ASMD)  (Hirai, 2002; Lindvall et al., 2004; Lunn et al., 2011). Incorporating 
the technology of blastocyst complementation and using chimeras, I aimed to create human 
donor-derived cells in porcine blastocysts, by manipulating a single gene of interest.  
1.1 Blastocyst complementation to Generate Organs and Cells 
  Blastocyst complementation was first developed by Chen et al. 1993, to evaluate RAG-2 
gene, whose deficiency causes the failure of B and T cell maturation. Knock out (KO) 
models for this system failed since it is embryonically lethal. But when they, injected 
normal or modified embryonic cells (ES) into a RAG-2 KO blastocyst, it lead to the 
development of chimeras with mature B and T cells, contributed by the ES cells. The 
growth of these chimeric embryos can be arrested at any stage and gene expression can be 
studied (Chen et al., 1993). Similarly, based on the experiments performed by Chen et al. 
the lens complementation system was developed. This system used the previously 
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mentioned aphakia mouse line, which fails to generate completely developed ocular lenses 
(Semina et al., 1998). Normal mouse ES cells were injected into mutant mouse blastocysts, 
and allowed to develop in a surrogate. These chimeric animals were able to generate lens, 
whose eyes responded to visual stimulus and were free of cataracts or other irregularities 
(Liégeois et al., 1996).  
1.1.1 Inter-specific mouse-rat chimeras 
The next step to using this technology was to try and create donor-derived organs in the 
recipient organism. Kobayashi et al. used a gene KO blastocyst complementation model 
with iPSCs or ESCs as the donor cells (Kobayashi et al., 2010). Induced pluripotent stem 
cells (iPSCs), were first developed by Takahashi and Yamanaka in 2006, by taking mouse 
fibroblasts and reprogramming them into pluripotent cells, similar to ESCs, by the 
overexpression of Oct4, Sox2, klf4 and c-Myc (OSKM) transcription factors via viral 
vectors (Takahashi and Yamanaka, 2006). Since then various adult human cells have been 
reprogrammed into iPSCs (Park et al., 2008; Takahashi et al., 2007; Yu et al., 2007).  In 
the 2010 paper by Kobayashi et al., they used a homozygous Pdx1deficient blastocyst. 
Pdx1 gene is necessary for pancreatic development. With the gene disrupted it created a 
niche, where mouse iPSCs or ESCs with the working Pdx1 gene took its place. The 
blastocysts were then transplanted into a surrogate, with the resulting chimeric pups having 
a donor-derived pancreas. After success of the experiment, an attempt was made for inter-
specific complementation. Thus, they used rat iPSCs or ESCs and injected them into Pdx1 
knock-out mouse blastocyst, and discovered that the resulting chimera possessed 
completely rat (donor-derived) pancreas, refer figure 1 (Kobayashi et al., 2010). Similarly, 
by using Sall1 KO mouse blastocyst, donor-derived kidneys were generated using mouse 
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iPSCs. Sall1 gene is critical for nephrogenesis and the gene disruption created another 
niche. When iPSCs with the working gene were injected, they occupied the niche thus, 
creating donor-derived kidneys (Usui et al., 2012). But, mice and rats are evolutionarily 
close and cannot be used for studies in humans. Thus, a scale-up was needed to have large 
enough organs to be used for human transplantation, if possible.  
 
FIGURE 1: The top panel depicts intra-specific complementation, where the resulting 
chimeric pups develops pancreas generated from donor PSCs from using a Pdx-/- blastocyst.  
The middle panel portrays inter-specific generation of chimera between a rat and mouse, 
with the mosaicism depicted in the resulting pup. The last panel shows inter-specific 
blastocyst complementation, where they generated rat pancreas in a mouse, by using rat 
PSCs and injecting into Pdx-/- mouse blastocyst (Kobayashi et al., 2010).  
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1.1.2 Blastocyst complementation using porcine blastocysts 
 To generate human sized organ for transplantation, researchers began to test if pigs were 
a feasible model system. Recently, it was demonstrated that blastocyst complementation 
could be performed using porcine blastocysts. Hes1 gene, which is required for biliary 
system development, was overexpressed under the Pdx1 promoter to inhibit pancreatic 
development in pigs. The Pdx1-Hes1 transgene was introduced into porcine oocytes by a 
process called “sperm injection mediated gene transfer” (Kurome et al., 2006) and the 
resulting fetuses were checked for disabled pancreatogenesis. To make things easier, 
fibroblasts from these pancreatogenesis disabled pigs were used as the donor nucleus, to 
perform SCNT-somatic cell nuclear transfer and generate pig clones with the Pdx1-Hex1 
transgene. SCNT is the process of injecting donor nuclei into a recipient oocyte to generate 
an offspring that is genetically identical to the donor (Campbell et al., 1996; Polejaeva et 
al., 2000). Thus, clone transgenic pigs with disabled pancreatogenesis were generated. The 
blastocysts from such male clones was used for blastocyst complementation. At the morula 
stage, it was complemented with blastomeres from a WT female pig embryo, cloned to 
express a fluorescent protein. This was then transferred to a surrogate and the fetuses were 
analyzed and the generation of donor-derived pancreas using porcine blastocysts was 
reported. A schematic representation of the procedure is depicted below in figure 2  
(Matsunari et al., 2013).  
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FIGURE 2: Schematic of generation of donor-derived pancreas using porcine blastocysts 
for complementation. Female WT porcine blastomeres with fluorescent dye were injected 
into male Pdx1-Hes1 disabled blastocyst, thus producing male offspring with a fully 
functional pancreas (Matsunari et al., 2013). 
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1.2 Roles of PITX3 gene 
  Pituitary homeobox 3 protein, which is encoded by PITX3 gene, is a transcription factor 
belonging to the PITX3/REIG homeobox gene family (Semina et al., 1998). In mice, the 
Pitx3 cDNA was isolated by using a probe containing Pitx2, and three different clones were 
identified. Since Pitx1 and 2 had already been discovered, and based on the homology of 
the third clone to the other two it was designated as Pitx3. Studies in mice have informed 
us that Pitx3 expression starts from E 10 (embryo day 10) in the lens placode and lens pit. 
At E 12, expression was observed in the midbrain, head muscle, tongue, sternum, and 
incisor primordia (Semina et al., 1997, 1998). Pitx3 was mapped to the mouse chromosome 
19 and is situated at the aphakia region, suggesting its involvement in the diseased 
condition. Aphakia is a recessive mutation, where aphakia homozygous mice are 
characterized by lack of lens, and closed eyelids, while heterozygous mice depict a normal 
phenotype (Semina et al., 1997).  Reiger et al., in 2001 reported not one but two deletions 
in Pitx3 gene as the cause for the aphakia phenotype, figure 3. These deletions include one 
major 1423 base pair (bp) deletion that removed exon 1 and the adjacent intron 1, as well 
as the promoter sequence, and a minor 642 bp deletion upstream of the major deletion that 
removed the transcription start site thus, disrupting the transcription of Pitx3 (Rieger et al., 
2001). Ptx3 is the rat homolog of Pitx3 (mouse). It was found to be important in the 
development of the mesencephalic dopaminergic system (mesDA or DA). Similar to the 
rat homolog, the human PITX3 gene was mapped to chromosome 10q25. The PITX3 
(human) gene exhibits an 88% homology with Pitx3 (mouse) gene at the nucleotide level, 
and a 99% homology at the protein level. PITX3 also functions in eye development, in 
addition to the development of the DA system (Semina et al., 1998).  
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FIGURE 3:  Diagram indicates the double- deletion of Pitx3 gene in aphakia mice. The 
horizontal arrows depict the transcriptional units.  Exons are indicated by the numbered 
boxes. The 625 bp minor deletion and the 1423 bp major deletion are separated by a 
wildtype sequence, 1640 bp in length. (Rieger et al., 2001) 
 
1.2.1 Function of Pitx3 in the development of the DA system and 
importance in Parkinson’s disease 
  The midbrain dopaminergic (DA) system is responsible for controlling various functions 
such as reward, cognition, emotional behavior and voluntary movement. The degeneration 
of these cells has been shown to result in PD, while the misregulation in the signaling of 
dopamine neurotransmitter is involved in various behavioral disorders and schizophrenia 
(Damier et al., 1999; Domburg and Donkelaar, 1991; Schultz, 2001; Seeman et al., 1993). 
There are 3 groups of DA neurons, and most reside in the ventral tegmental area (VTA) 
and substantia nigra (SN), while others are found in the retrorubral field (RRF). These 
together, comprise the mesencephalic system. The DA neurons in the SN project and 
innervate the striatum, especially the caudate and putamen and, control voluntary 
movements. In PD, preferential degradation of these nigrostriatal neurons has been 
observed (Domburg and Donkelaar, 1991; Lindvall et al., 1984).  
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  Many transcription factors have been associated with the development of DA neurons 
such as Lmx1b, Nurr1 and Pitx3. They are expressed in the dorsal midbrain to a greater 
extent and partake in neuron migration and maturation (Nunes et al., 2003; Smidt et al., 
2004a). Other transcription factors include fibroblast growth factor 8 (FGF8), sonic 
hedgehog (Shh) and engrailed 1 and 2. Shh along with FGF8 is important early in the 
development of the brain from the neural plate and commit the cells to a particular part of 
the midbrain from which dopaminergic neurons later arise. Shh is later expressed in the 
lateral part of the midbrain to a greater extent, than in the medial part, which may lead to 
the formation of subtypes of dopamine neurons (Hynes and Rosenthal, 1999; Hynes et al., 
1995a, 1995b; Lin and Rosenthal, 2003; Wallén et al., 1999). Nurr1 orphan nuclear 
hormone, has been proven essential for the maturation of the mesencephalic DA neurons. 
It has been shown that, Nurr1 knock out (KO) mice do not express the enzyme tyrosine 
hydroxylase (TH), an essential component in the biosynthesis of dopamine 
neurotransmitter (Baffi et al., 1999; Castillo et al., 1998; Le et al., 1999; Saucedo-Cardenas 
et al., 1998; Wallén et al., 1999; Witta et al., 2000; Zetterström et al., 1997, 1997).  Lmx1b; 
LIM homeodomain transcription factor, is required for the specification of mesencephalic 
DA neuron progenitors (Smidt et al., 2000). Pitx3 expression is now required for further 
development, and the gene falls downstream of the transcription factors stated above. 
  As previously mentioned, Pitx3 has been reported to be a particularly important 
transcription factor in nigrostriatal DA neuron development. Pitx3 expression has been 
reported in the developing eye and striatum by E 11 and continues throughout adulthood 
in mice (Gage et al., 1999; Smidt et al., 1997). Previous studies have shown that Pitx3 
expression is localized specifically in the SN and VTA, but is important for the 
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maintenance of just the SN neurons. Mutation studies in aphakia mice has shown an 
absence of TH in the SN, especially the caudate and putamen, while leaving the VTA 
undisturbed (Hwang et al., 2003; Nunes et al., 2003). Studies have also shown the 
requirement of Pitx3, for the terminal differentiation of neurons in the mes-DA system 
(Smidt et al., 2004b). In the mouse midbrain TH, is expressed at E11, right after Nurr1 
which is expressed at E10 and around the same time as Pitx3 expression (Maxwell et al., 
2005). It was observed that the SN and VTA differ in their requirement of Pitx3, since two 
different groups of DA neurons were discovered. The VTA, which originates from the 
medial neuroepithelium, first expresses TH before expressing Pitx3, thus it does not require 
Pitx3 for TH activation. On the other hand, the SN arising from the ventrolateral part of 
the neuroepithelium, first expresses Pitx3 and those cells then expresses TH, which gives 
rise to mature dopaminergic neurons. Thus, Pitx3 is essential for the maturation and 
maintenance of these neurons in the midbrain (Kawano et al., 1995; Maxwell et al., 2005; 
Smidt et al., 2004b). It has since been reported that these SN DA neurons have a high 
susceptibility of degeneration in Parkinson’s disease. (Barzilai and Melamed, 2003).  
1.2.2 Function of Pitx3 in ocular development  
 The development of the eye has been examined in various animal models including 
zebrafish (Shi et al., 2005), xenopus (Grainger, 1992; Henry and Grainger, 1987; 
Khosrowshahian et al., 2005; Ogino et al., 2012), chicken and mouse (Mochizuki and 
Masai, 2014; Ogino et al., 2012).  
  The eye embryonic development has been used as a cell differentiation model and has 
been thoroughly investigated to delineate its various stages (McAvoy et al., 1999).   After 
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gastrulation, the lens develops from the pre-placodal ectoderm (PPE), assisted by various 
transcription factors. The different stages of vertebrate lens development along with the 
major signaling factors, are depicted in figure 4 (A-G). The cells around the anterior neural 
plate begin to express certain pre-placodal genes like, Hes4 (Murato and Hashimoto, 2009), 
Dlx- 3, 5, 6 (Akimenko et al., 1994; Bhattacharyya et al., 2004; Feledy et al., 1999; Luo et 
al., 2001; Quint et al., 2000; Yang et al., 1998) to name a few, refer figure 4H. The 
presumptive lens ectoderm or (PLE) is included in the PPE and, in the next stage of 
development the PLE genes such as, Pax6; which is required for lens induction (Grindley 
et al., 1995; Li et al., 1994; Nornes et al., 1998; Walther and Gruss, 1991; Zygar et al., 
1998) as well as, Six3 (Bovolenta et al., 1998; Kobayashi et al., 1998; Oliver et al., 1995; 
Zhou et al., 2000), begin to be expressed. Pax6 mutations present a ‘small eye’ phenotype 
in rats and mice, while in humans it is responsible for the absence of an iris (Quiring et al., 
1994). All the above mentioned genes facilitate ‘lens specification’. Eventually, the PLE 
makes contact with the optic vesicle, which is formed by the protrusion of the presumptive 
retinal region, around the same time. Once this initial contact has taken place, the cells of 
the PLE start to elongate to give rise to the lens placode. Differentiation genes such as, 
FoxE3 (Blixt et al., 2000; Shi et al., 2006), Mab21l1 (Yamada et al., 2003) and importantly, 
Pitx3 are involved in this process (Pommereit et al., 2001; Semina et al., 2000; Zilinski et 
al., 2005).  
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FIGURE 4: The above figure depicts the different stages of vertebral lens and retinal 
development. A- G is a pictorial representation of different stages of development of the 
eye in xenopus after gastrulation. H represents the different stages of lens and retinal 
development in xenopus, along with the various important signaling factors such as Wnt, 
BMP, FGF and Notch. While below it are various transcription factors, that are required at 
different time points during development. The length and placement of the arrows depict 
when they start expression, continuing through the stage they are expressed. I is an in-situ 
hybridization analysis of Pax6, in a xenopus embryo, with the presumptive lens and retina 
represented (PLE and PR, respectively). (Ogino et al., 2012) 
 
  The elongated cells in the lens placode begin to differentiate and form primary lens fibers, 
where cell cycle is arrested, the cells become enucleated and lose many other organelles 
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such as mitochondria and golgi. Due to an upregulation of crystallins such as beta and delta 
crystallins, the cells get crystallized (Mcavoy, 1980; Piatigorsky, 1981). At the anterior 
portion of the lens, a single layer of epithelial cells exist, that retain their nucleus and 
membrane bound organelles, remain in the cell cycle. These epithelial cells, surrounding 
the lens fiber cells, proliferate and differentiate into fiber cells when required and Pitx3 is 
said to be essential specifically for this differentiation (Ogino et al., 2012; Shi et al., 2005).   
 
FIGURE 5: Major transcription factors involved in regulating the ocular lens 
development. Depicts Pitx3 action on lens, downstream of Pax6 and Six3, major lens 
induction genes, as well as, FoxE3 another major differentiation gene (Mochizuki and 
Masai, 2014).  
  
  Pitx3 expression in mice, can first be observed during lens placode formation, figure 4H 
(Medina-Martinez et al., 2009; Pommereit et al., 2001). As previously stated by Semina et 
al., 1998 and 2000, the aphakia condition is caused by a natural mutation of the Pitx3 gene 
in mouse. This deficiency in gene expression leads to failure in the development of the lens 
epithelium and lens fibers from the lens vesicle, which eventually leads to the degeneration  
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of the primary lens fiber cells (Medina-Martinez et al., 2009; Rieger et al., 2001). Thus, 
Pitx3 is required for lens epithelial cell population maintenance, and indirectly influences 
the maintenance of lens fibers, formed by the differentiation of lens epithelial cells 
(Mochizuki and Masai, 2014; Ogino et al., 2012). Pitx3 protein also plays a crucial role in 
retinal cell maintenance. Loss of differentiated retinal neurons or cell death, with 
significant reduction of certain retinal cell types has been reported in Pitx3 mutated 
animals, providing evidence of its involvement in retinal development and maintenance 
(Khosrowshahian et al., 2005; Shi et al., 2005). Aphakic mice also present with blindness 
due to absence of lens, pupil and iris, a condition called micropthalmia. The eyelids are 
closed, with retinal folds invading the vitreous chamber. Due to the malformation of the 
anterior chamber,  the lens retains its connection to the cornea, and at the lens stalk stage, 
development is arrested (Varnum and Stevens, 1968). Finally, mutations in the human 
PITX3 gene have been observed in many autosomal dominant cataracts, as well as, ASMD 
(Semina et al., 1998).  Many cell replacement and transplantation therapies are under 
investigation. But, in order to scale these studies to a human level, larger animal models 
that better mimic human conditions are required. Porcine models would be a step ahead of 
mouse or rat models. Humanized mouse models have been widely used to model various 
diseases, but unfortunately, they do not mimic the diseased conditions as they present 
themselves in humans (Lunney, 2007). The technology of blastocyst complementation 
maybe the next step, by providing a way to analyze human genes and human cells at any 
stage of development. 
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1.3 Gene editing with TALENs 
Evaluation of gene function is possible by various powerful methods of targeted gene 
inactivation, such as via homologous recombination (HR). Nevertheless, several 
limitations such as low efficiency of correct insertions into the target genome, labor-
intensive and time-consuming selection and screening, and potential adverse mutagenesis 
(Capecchi, 2005). New approaches of genome editing, such as transcription activator like 
nuclease (TALENs), zinc finger nucleases (ZFN) and CRISPER-Cas9, have emerged in 
the past decade and have enabled researchers to manipulate a variety of genes in various 
organisms and cells. The basis of this technology is the use of engineered nucleases that 
contain particular DNA binding domains and are fused to various DNA cleavage units, 
which has enabled precise and efficient genetic modifications by the induction of double 
stranded breaks at targeted regions on the DNA strand. The double stranded breaks are then 
repaired by homology directed repair and non-homologous end joining (NHEJ) (Carroll, 
2011; Urnov et al., 2010; Wyman and Kanaar, 2006). Transcription activator-like effectors 
(TALE) are specific DNA binding proteins. They were fused to the Folk1 nuclease 
catalytic domain, which created double stranded breaks. In cells, double stranded breaks 
are usually repaired by NHEJ and usually causes insertions or deletions. Thus, this strategy 
was used to delete or disrupt a Pitx3, the gene of interest for our experiments (Cermak et 
al., 2011; Christian et al., 2010). 
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1.4 Complementation of porcine parthenogenic Blastocysts using human 
pluripotent cells 
  In our current research we aimed to interrogate the role of PITX3 gene during 
development, and investigate if human dopaminergic neurons and lens could be developed 
using blastocyst complementation. Previous work has established that complementation 
studies in porcine blastocysts using human stem cells is in-fact possible (Swaminathan. P., 
2014). We started by investigating the integration of different human pluripotent stem cells 
such as, human iPSCs (hiPSCs), umbilical cord blood stem cells (UCBSCs) and human 
multipotent adult progenitor cells (hMAPCs) (Nan et al., 2005; Xiao et al., 2005), into the 
inner cell mass (ICM) of porcine parthenogenic blastocysts. In order to visualize and 
quantify the integration of human cells, immunohistochemistry (IHC) was performed using 
the blastocysts, they were labeled with an antibody against human nuclear antigen (HNA). 
Parthenogenic zygotes at Day 0 were generated by electrical activation and injected with 
approximately 10 human stem cells. They were then cultured until they reached the 
blastocyst stage (6 days after injection) and fixed and stained for HNA on day 7.  
 
FIGURE 6: Immunohistochemistry of day 7 porcine parthenogenic blastocyst injected 
with UCBSCs and labeled with anti-human nuclear antigen or HNA (HuNu). A shows all 
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the cells labeled with DAPI (blue). B indicates the presence of human cells that stained 
positive for HNA (red). While panel C is a merge. Scale: 50μm (Swaminathan. P., 2014).   
 
The number of cells integrated into the ICM was then quantified, after which the 
blastocysts containing human pluripotent cells were transferred to a surrogate and allowed 
to remain 28 days in gestation. They were then excised, and fixed, embedded and sectioned. 
The sectioned tissues were stained for HNA, to visualize the contribution of human cells 
in the organs. (Swaminathan. P., 2014).   
 
FIGURE 7: Identification of human cells in embryos generated via blastocyst 
complementation of porcine parthenotes. A depicts a 28 day old parthenote. B is a 
florescent image, of a section of liver tissue from the parthenote, stained with anti-Human 
nuclear antigen (HNA). Red= HNA; Blue= DAPI. Scale, A: 1000μm and B: 100μm 
(Swaminathan. P., 2014).  
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1.5 Generation of human-porcine chimera using PITX3 KO blastocysts 
for complementation with hiPSCs and UCBSCs.  
 Based on the success of generating human-porcine pathenogenic embryos with 
contribution of the human stem cells in organ development, the next step was to create a 
niche for these human cells to specifically integrate. The study was designed similar to the 
ones by Matsunari et al, and Kobayashi et al., as previously mentioned. But for our studies 
to generate a PITX3 KO we used Transcription Activator-like Effector Nucleases or, 
TALENs for gene editing.  Recently, Carlson et al. demonstrated the efficiency of TALENs 
in generating knock outs in porcine fibroblasts. A TALEN pair with an EGFP reporter, 
used as indicator, was injected into zygotes to confirm integration. A pair of gene specific 
TALEN mRNAs were injected to target specific genes and produced insertions or 
deletions, thus generating KO in porcine fibroblasts. Clones were created using chromatin 
transfer (Carlson et al., 2012).   
  For the purpose of our system, TALEN mRNAs specifically targeting genes Nurr1, 
PITX3 and Lmx1a were used. PCR analysis confirmed the disruption of the genes, thus 
successfully generating porcine KO fibroblasts, shown in figure 8  (Carlson et al., 2012, 
Swaminathan . P., 2014) Pitx3 KO porcine embryos were then generated by performing 
SCNT using chromatin from Pitx3-/- fibroblasts and injecting into porcine oocytes. These 
blastocysts were transferred into a surrogate sow and allowed to remain 62 days in 
gestation thus, generating Pitx3 KO porcine embryos. Bi-allelic KO was confirmed on 
analyzing tissue sample from each embryo (Swaminathan. P., 2014). 
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    Similarly we used the previously generated Pitx3 KO morulae and performed blastocyst 
complementation studies by injecting human iPSCs and UCBSCs. These were cultured 
until they reached the blastocyst stage and were then transferred to a surrogate sow for 
development up to 62 days in gestation.  
 
FIGURE 8: Gene knock-outs in porcine fibroblasts mediated by TALENs. A depicts the 
TALEN constructs with specific cleavage sites for Lmx1a, Nurr1, and Pitx3 genes. B is the 
PCR analysis of porcine fibroblasts to confirm the cleavage of the genes after TALEN 
mRNA targeting. The cleavage products are indicated by double arrows (Swaminathan. P., 
2014).  
 
Thus, we generated 3 groups of embryos: Pitx3 KO porcine embryos and the 2 chimeric 
groups, Pitx3 KO blastocysts complemented with hiPSCs and Pitx3 KO blastocysts 
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complemented with UCBSCs. Wild type (WT) porcine embryos, whose development was 
arrested at 62 days in gestation were used a controls. In this particular report, the focus will 
be on the contribution of PITX3 in the generation of a normal lens in the KO embryos. The 
eyes from the porcine embryos were excised, fixed and embedded. The tissue was then 
sectioned for analysis. Morphology of the eyes was assessed with histological analysis and 
IHC was performed on the tissues using and antibody against HNA to detect the presence 
of human cells. Although, we were not able to detect the presence of any human cells in 
the lens or retina, we were however able to see certain differences in retinal morphology 
in some of the chimeric embryos complemented with UCBSCs. Here we report a method 
of successfully generating a human-porcine chimera, which has been highly valuable in 
assessing the significance of Pitx3 for the normal embryonic development of the eye. 
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METHODS AND MATERIALS 
TALEN DESIGN 
   The knockouts for the interrogation of PITX3 gene were generated through somatic cell 
nuclear transfer (SCNT) as described previously by Carlson et al, 2012.  A brief description 
of TALEN design is as follows, ‘TALE-NT’ software was used to design the TALENs 
(Cermak et al., 2011). Each TALEN pair that was compatible for Golden Gate cloning had 
intermediate arrays, which were cloned into vectors:  RCIscript-GoldyTALEN, pC-
GoldyTALEN, RCIscript-+231-TAL and Pc-+231-TAL. In a 20μl digestion-ligation 
reaction that consisted of T4 DNA ligase (50 units, New England Biolabs), Esp31 (10 units, 
Fermentas) and diluted in 1X ligase buffer (New England Biolabs), 150 ng of each of the 
plasmids along with the desired backbones were added with the arrays to join them into 
the vectors. The reaction mixture was then incubated in a thermocycler for 10 cycles, 5 
minutes each at 37°C and another 10 minutes at 16°C. It was then heated for 5 minutes to 
50°C and another 5 minutes to 80°C. About 2μl of the reaction mixture was transformed 
into E.Coli and plated on LB plates with antibiotics (Carlson et al., 2012). The TALENs 
were then transfected into cultured fibroblasts to produce clones. The fibroblasts were 
cultured in DMEM containing FBS, and the transfections were carried out using Fibroblast 
nucleofection kit (Lonza/ Amxa Biosystems).  The transfected cells were plated and clones 
collected and the KO was confirmed by PCR analyses. Porcine oocytes were obtained and 
cultured following the protocol mentioned in Carlson et al., 2012. The DNA from these 
knockout fibroblasts were then transferred to an enucleated porcine ovum to create knock 
out blastocysts (Carlson et al., 2012). 
21 
 
1. BLASTOCYST INJECTIONS 
  As previously mentioned, Pitx3 gene was knocked out from porcine fibroblasts via gene 
editing using TALENs, and KO blastocysts were generated (Carlson et al., 2012). Some of 
the Pitx3 KO morulae at day 4 were microinjected with human stem cells to create 
chimeras. Specifically about 46 day 4 Pitx3 KO morulae were microinjected with 7-10 
human iPSCs, another set of 72 day 4 Pitx3 KO morulae were microinjected with about 10 
UCBSCs and as a control for the study, un-injected knock out porcine blastocysts  (KO) 
and wild type (WT) porcine blastocysts were used. These were then transferred into a 
surrogate sow, to develop for 62 days. For the complete protocol regarding preparation of 
donor cells for cloning, refer to Rodriguez-Osorio et al., 2009 and Swaminathan P, 2014.  
Recipient sows, about 280-320 lbs were administered with 15mg of Matrix (Altrenogest, 
Merck) which was mixed into the feed for about 14-17 days to prepare them to serve as 
surrogates. To induce superovulation 1,500 IU of PG600 (Intervert) was administered 
intramuscularly 24 hours after the last Matrix feeding. 82 hours later 750 units of hCG 
(Intervet) was administered by intramuscular injections. About 120 hours post hCG 
embryos were transferred into the sows for development. 
2. FETAL HARVEST AND TISSUE PROCESSING 
 The fetuses were kept 62 days in gestation, which is a little over half way point in pigs, 
since Pitx3 gene expression is strong around E 12.5, a little over half way through the 
gestation period in mice (Semina et al., 1998, 2000). After 62 days, the fetuses were 
removed. Two groups of human-porcine chimeric fetuses were obtained for, hiPSCs; 4 
fetuses and UCBSCs; 8 fetuses, along with 13 KO and 16 WT fetuses as controls. Once 
22 
 
the fetuses were excised, a sample from each was taken for genotyping to confirm the 
efficient knockout of the Pitx3 gene. Fetuses were perfused with PBS, prior to perfusing 
with 4% PFA. The organs were then dissected out and fixed by immersing in 4% PFA 
overnight and the following day were transferred to 15% sucrose. Tissues were left in 
sucrose for about 12 hours or until the tissue sank to the bottom, completing the fixation 
process. They were then embedded in OTC. 
EYES: The eyes were processedas described above. They were excised and fixed with 4% 
PFA. They were then immersed in 15% sucrose and left overnight. The following day they 
were embedded in OTC, using dry ice to freeze them and stored at -80°C. Human fetal 
eyes were obtained commercially from Advanced Biomedical Research Inc., New Jersey 
and processed in the same manner. 
CRYOSECTIONING: The tissue blocks were then cut into 8μm sections using a cryostat 
and transferred onto slides. They were air dried, preferably overnight, to ensure that the 
tissue adheres to the slides better. They were then stored at -20°C. Both right and left eyes 
of all the chimeras were sectioned and mounted onto slides, while only the right eyes were 
selected for sectioning for WT and KO porcine eyes, for the sake of convenience.  
3. PHENOTYPIC ANALYSIS 
  Once the fetuses were removed after 62 days, the first step was to perform a phenotypic 
analysis of the eye-lids. It was previously reported that the Pitx3 null animals exhibit 
closure of eyelid, or present with opaque eyelids (Rieger et al., 2001).  The 4 groups of 
porcine fetuses hiPSC, hUCBSC, KO and WT were excised and the different organs were 
dissected out. The eyes were photographed before excision for documentation. The 
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photographs from the 4 groups were randomly arranged and a blind assessment was done 
to see if the groups could be sorted by the phenotype. Thus, the eyes from the four groups 
of animals were randomly arranged and were shown one after another, while the observers 
who were blinded as to the group from which the eyes were derived, categorized each fetus 
as ‘open’ or ‘closed’ eyes. In other words, transparent or opaque eyelids. This procedure 
was repeated for 9-WT, 10-KO, 8-UCBSC-chimera and 4-hiPSC-chimera. An eye index 
was assigned to each fetus based on the percentage of the blinded evaluators that deemed 
the eyelid in the ‘open’ state. The overall averages of eye lid index was compared between 
each of the four groups. Statistical differences in eyelid indices were determined using 
ANOVA and post hoc pair-wise comparison.  
4. HEMATOXYLIN AND EOSIN STAINING (H&E) 
  Once the eyes were sectioned laterally, a sample of 5 slides, with 4 sections on each slide, 
totaling 20 slices of each eye was stained with H&E to look for structural differences 
between the 4 groups. The slides were selected in such a way that different areas of the 
lens would be present for comparison. Thus, one slide at the beginning of the lens (i.e. 
where the lens just starts to show up), one at the end, and 3 in between were selected for 
each of the samples. Thus, the 20 slices of eyes that were stained represented all the facets 
of the eye. Since our main concern is the development of the lens, only those sections 
consisting of lens tissue were selected. The progressive staining system was used, where 
the tissues on the slides were first rehydrated with 100 to 50% ethanol washes 2min each 
and then, stained with hematoxylin pH 4 for 4min. Excess hematoxylin, was then removed 
by acid washes, by dipping the slides in HCL in 70% ethanol and ammonia in 70% ethanol, 
1 and 5 times respectively. The slides were then rinsed under running tap water for about 
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40 sec.  The counter stain Eosin pH 4, was then applied for about 1.5 to 2 min and rinsed 
under running tap water for 40 seconds, followed by 30 sec in 90% ethanol to remove 
excess eosin. This was then followed by acid washes with 70% ethanol to 100% ethanol. 
The slides were then air dried, and the cover slip was applied using U-kit and the slides 
were sealed.  
5. IMAGING 
 SLIDE SCAN:  The sample slides were then scanned using a TISSUEscope LE slide 
scanner made by Huron Technologies at the University imaging center (UIC), at University 
of Minnesota. The images were analyzed using macroscan a software also made by Huron 
Technologies. The size of these images is so large that they can only be opened using Huron 
viewer, after which they were down sized and were split apart using Fiji/ Image J.  
CONFOCAL IMAGING: Immunostained slides were imaged using Nikon NiE C2 Upright 
Confocal microscope at the UIC, University of Minnesota. A series of z-stack images were 
obtained, and were compressed to depict the highest fluorescent intensity.  
Slides used for IHC to detect HNA positive cells, were imaged using a Lieca fluorescent 
microscope at the University of Minnesota. 
 
6. IMMUNOHISTOCHEMISTRY  
IHC was performed on human-porcine chimeric eyes using an antibody against Human 
Nuclear Antigen (HNA) to identify human cells. The slides containing the tissues were 
washed with Phosphate buffered saline (PBS) of pH 7.4 containing 0.1% Tween 20, for 
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about 5min each in coplin glass jars, repeated thrice. The J-Block (PBS-T + 1% Bovine 
serum albumin {BSA}) with 1% Tween 20 added to it before use, was used to permeabilize 
the tissue for 10min. The slides were then incubated for 1 hour in normal donkey serum 
diluted in PBS containing 10% triton (TX-100) and BSA, to prevent non-specific binding 
of the primary antibody. HNA primary antibody (1:400, Rockland antibodies, species: 
mouse polyclonal) was diluted with normal donkey serum in PBS-TX-100-BSA. Tissue 
sections were incubated overnight at 4°C in primary antibody. The subsequent day the 
sections were washed with PBS-TX-100-BSA, 3 times/ 5 minutes each, in coplin jars, after 
which they were incubated for 2 hours in either a donkey anti-mouse 555 Alexa Fluor 
secondary antibody (1:1000, Invitrogen), diluted in PBS-TX-100-BSA. The slides were 
washed again in PBS-TX-100-BSA, 4 times/ 5 minutes each in coplin jars. DAPI a nuclear 
localization stain, used at concentration of 1:1000 and made in PBS was applied for 5 
minutes. The slides were then subjected to 3 final washes using PBS-TX-100-BSA, 5 
minutes each, after which they were air dried and mounted. Immu-mount was used to 
preserve the samples and fix on the cover slip and the slides were sealed with a clear nail 
polish. 
  
Retinal Markers 
A) Antibodies to arrestin bind to rod photoreceptors of the retina. The slides containing the 
tissues were washed with Phosphate buffered saline (PBS) of pH 7.4 containing 0.1% 
tween 20, for about 5min each in coplin glass jars, repeated twice. The J-Block (PBS-T + 
1% BSA) with 1% Tween 20 added to it before use, was used to permeabilize the tissue 
for 15min. The slides were incubated for 1 hour 30 minutes in normal donkey serum diluted 
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in PBS containing BSA and 10% triton (TX-100), to prevent non-specific binding of the 
primary antibody. The sections were incubated with anti-arrestin antibody (1:400, EnCor 
Biotechnology Inc., species: mouse) and incubated overnight at 4°C.  The subsequent day 
the sections were washed with PBS-TX-100-BSA, 4 times for about 2 minutes, using wash 
bottles. A goat anti-mouse 488 Alexa Fluor (1:500, Cell Signaling), diluted in (NGS) 
normal goat serum in PBS-TX-100-BSA, was used as the secondary antibody. The washes 
were repeated in the same way about 5 times/ 2 minutes each, followed by DAPI for 5 
minutes and 3 final washes, 2 minutes each. The slides were then air dried and mounted, 
in the manner described above. 
B) Antibodies against AP2alpha recognize amacrine cells and cells in the ganglion cell 
layer of the retina (Guduric-Fuchs et al., 2009). Antigen retrieval was performed on the 
sections using sodium citrate buffer, pH 6, containing 10mM of sodium citrate in 0.05% 
Tween 20, and incubated in a steamer for 30 minutes, prior to staining. The staining 
procedure was same as the one mentioned above. The slides were incubated with anti-
AP2alpha (1:50, Developmental Studies Hybridoma Bank, species: mouse) and diluted 
using normal goat serum with PBS-TX-100-BSA. A goat anti-mouse Alexa Fluor 488 
(1:500, Cell Signaling) diluted in PBS-TX-100-BSA was used as the secondary antibody. 
C) Antibodies against Islet1-1A9 recognize horizontal, ganglion, bipolar and amacrine 
cells in the retina (Guduric-Fuchs et al., 2009). Antigen retrieval was performed using the 
previously mentioned, sodium citrate buffer and incubated in a steamer for 30 minutes, 
prior to staining using the IHC protocol previously mentioned. The Islet1 primary antibody 
(1:50, Developmental Studies Hybridoma Bank, species: mouse) was diluted to a working 
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concentration using normal goat serum in PBS-TX-100-BSA. Goat anti-mouse Alexa 
Fluor 488 (1:500, Cell Signaling) was used as the secondary.  
D) To label astrocytes, antibodies against Glial fibrillary acidic protein (GFAP). Staining 
protocol were the same as above. The slides were labeled with anti-GFAP antibody (1:500, 
DAKO, species: rabbit) was diluted using normal goat serum in PBS-TX-100-BSA. The 
secondary antibody used was a goat anti-rabbit Alexa Fluor (1:500, Life Technologies).  
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RESULTS 
3.1 PHENOTYPIC ANALYSIS OF EYES 
  Once the porcine-human chimeric embryos were harvested after 62 days in gestation, they 
were excised and organs were harvested. The porcine embryos were documented as shown 
in figure 9, before they could be perfused and organs were dissected. From the literature 
we have gleaned that aphakia mice exhibit a closed eyelid phenotype (Rieger et al., 2001). 
Thus, our first step was to evaluate if such an eyelid phenotype could be recapitulated in a 
porcine model of Pitx3. A photograph depicting the eye of each porcine embryo, wild type 
pig (WT), Pitx3 KO pig (KO), Pitx3 KO injected with hiPSCs (KO+hiPSC) and Pitx3 KO 
injected with hUCBSCs (KO+hUCBSCs) were presented to lab members in a random 
order. The assessment was blind, and the pictures were numbered 1 through 37 and 
presented in random order. Each individual was required to look at the picture and note if 
the eyelid was transparent (representing an open eye) or if the eyelid was opaque 
(representing a closed eye).  
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FIGURE 9: Representative pictures of porcine embryos used during the phenotypic 
analysis. A: Represents a WT porcine embryo. B: KO porcine embryo C: KO+hiPSC 
chimeric embryo D: KO+hUCBSC chimeric embryo. As, represented above the pictures 
were not named and presented in a random order, in order for the assessment to remain 
impartial.   
 
 
FIGURE 10: Represents the list of eyes presented and the resulting averages of blind 
assessments. 
 
 The assessment of each lab member was collected and quantified, as shown in figure 10. 
Based on the result of the assessment, a graphical representation was created using 
ANOVA a statistical analysis tool, that provides the ‘open eye-index’ for chimeric eyes, 
depicted in figure 11. Each embryo is represented as an individual point. The WT and KO 
eyes provided the positive and negative controls, respectively. Each group WT, KO, 
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KO+hUCBSC and KO+hiPSC, are represented with a different color. The assessment from 
each individual for each embryo was taken and an average was calculated. The eye index 
was 10 percent if all individuals said open, 90 percent if one individual said closed and 
everyone else stated open, and so on. The ‘open eye index’ was calculated for each, and 
from the graph it can be noted that most of the WT eyelids had an ‘open eye index’ of 
100%, while the KO had the least, with many falling at 0%. The KO+hUBSC porcine 
embryos had the greatest distribution, while many fell in the range of the KOs, one in 
particular had a high index and placed in the WT range. The KO+hiPSCs, had a lower 
distribution than those embryos injected with UCBSCs. They placed lower and did not 
have eye indices greater than 50 percent, were closer to the KOs. Thus, from the following 
analysis we conclude that those embryos injected with human cells, had some improvement 
in eyelid development. Although, many fell closer to the KO range, there were few among 
the KO+hUCBSC group that fell in the WT range. Thus, based on the phenotype chimeric 
embryos P2E1, P2E3, P2E4, P2E6, P2E8 and P1E2 were concluded to have a better 
development of the eyelid, possibly due to the presence of human cells.  
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FIGURE 11: Graphical representation of the ‘open eye index’. RED: WT porcine eye-lids 
have a very high ‘open eye index’, with maximum falling at 100%. GREEN: KO porcine 
eye-lids have a very low ‘open eye index’ with most falling at 0%. BLUE: KO+ hUCBSC 
chimeric porcine eye-lids show a wide distribution, with most falling in the KO range, 
while a few falling in the WT range.  PURPLE: KO+hiPSC chimeric porcine eye-lids show 
a distribution of eye indices, but fall in the KO range, with none showing greater 60%  
‘open eye index’. 
 
3.2 ANALYSIS OF EYE HISTOLOGY VIA H&E STAINING 
 Once the eyes were analyzed for the phenotype, they were embedded in OCT and frozen 
and stored in -80°C. The tissue blocks were cryosectioned at 8micro meters onto slides for 
further analyses. The next step was to characterize the morphology of the eyes. According 
to studies done in Pitx3 KO mice, a lack of lens has been reported (Rieger et al., 2001; 
Semina et al., 1998; Varnum and Stevens, 1968).  Based on our phenotypic analysis, a few 
chimeric eyelids were seen to have an improvement compared to the KO, thus we 
proceeded to see if the structural morphology of those eyes matched the phenotype. It was 
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also our goal to investigate if the KOs lacked lenses, while the chimeras presented with 
lenses due to the presence of human cells which provided the expression of PITX3 gene 
for lens development. The eye sections were thus stained for Hematoxylin and Eosin 
(H&E), to visualize and analyze the structural morphology of the eyes. Hematoxylin stains 
nuclei purple, while the counter stain Eosin stains the lens pink. The right eye from each 
embryo was used for staining. 5 slides were picked from each embryo, one at the beginning, 
middle and end of the lens and two in between.  Figures 12 through 15, represent the largest 
(middle) section of eyes, for each embryo, from each of the four groups. It can be noted 
that the retina stains purple, while the lens stains pink since it lacks nuclei.  
 
 
 
FIGURE 12: H&E stains of human fetal eye about 21 weeks old (A) and 62 day old WT 
porcine eyes (B &C). B: P3E12 C: P3E10. R depicts the purple retina. While the L 
represents the pink whole lens. These were used as a positive control, to depict how the 
histology of a normal human and porcine eye looks like. Scale = 100μm. 
Nomenclature: P3E12 is Pig 3, embryo 12. Similarly, P2E2 is pig 2, embryo 2 
and so on. 
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FIGURE 13: KO porcine eyes stained for H&E. D-K: are all of the KO used for this study, 
starting from P4E1 through to E8, while L: P5E1. R depicts the purple retina. While the L 
represents the lens, in the structure that henceforth will be referred to as ‘lens-like 
structure’. Scale = 100μm. 
 
 
 
34 
 
FIGURE 14: H&E stains of hiPSC injected chimeric embryos. M-P: are P1E1 to E4 
respectively. R depicts the purple retina. While the L represents the lens, within the ‘lens-
like structure’.  Scale = 100μm. 
 
 
FIGURE 15: hUCBSC injected chimeric eye sections, stained with H&E. Q-R: hUCBSC 
chimeras, P2E1 through E8 respectively. R depicts the purple retina. While the L 
represents the lens, within the ‘lens-like structure’. Scale = 100μm. 
 
The clump of cells at the center of the eye that stained pink and was in conjunction with 
the cornea, with purple retinal cells mingled, was designated as ‘lens-like structure’. Most 
of the KO presented with a thin outer layer of retinal pigment epithelial layer (RPE), while 
most of the retinal cells were clumped together with the lens in ‘lens-like structure’ that 
stains mostly purple but pink in certain areas, as depicted in the above figures. They lacked 
the thick retinal lamination that can be noticed in the WT and human eyes. The chimeras 
however, portrayed similar morphology as the KOs and little difference was seen between 
them and the KOs, even though they were complemented with human cells. But, a few of 
the hUCBSC+KO chimeras, did present with a thick retinal lamination along with the 
‘lens-like structure’, in R, T and X of figure 15. Thus, perhaps this illustrates a certain 
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improvement, possibly due to the presence of human cells. In saying so, this retinal 
lamination can be noticed in a few of the KOs as well, seen in I, K and L in figure 13. Thus, 
in order to confirm that the changes in the hUCBSC+KO chimeras may be due to the action 
of hUCBSCs, we decided to stains the eyes for human nuclear antigen to detect these 
human cells.  
 
3.3 IMMUNOHISTOCHEMISTRY FOR THE DETECTION OF 
HUMAN CELLS 
 Since, a few of the chimeras presented with a good retinal lamination along with the ‘lens-
like structure’, our hypothesis was that the complementation with human cells may have 
ameliorated the KO phenotype by providing the expression of PITX3 gene for lens 
development. Thus, we decided to perform IHC to the sections of all the chimeric eyes for 
human nuclear antigen (HNA). WT porcine eyes and the KO were used as negative control 
as portrayed in figures 17 and 18, while human fetal eyes were used for positive control 
shown below in figure 16. The sections were stained with an antibody against HNA 
according to the protocol mentioned in the methods section, shown in figures 19 and 20.  
 
FIGURE 16: IHC of Human fetal eye labeled with anti-HNA antibody. Depicts the 
epithelial cell layer at the anterior part of the lens. Objective = 20X; Scale: 100μm. A: 
DAPI = Blue. B: HNA= Red. C: Merge = Purple.  
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FIGURE 17: IHC of WT porcine eyes labeled with anti-HNA antibody. Depicts WT retina 
labeled with DAPI. Objective = 10X; Scale: 100μm. A: DAPI = Blue. B: HNA= Red. C: 
Merge = Purple. D: A merged 20X magnification of the epithelial layer at the anterior 
region of the lens. Scale: 100μm.  
 
 
FIGURE 18: KO porcine eyes stained with anti-HNA antibody. The image represents the 
‘lens-like structure’. Objective = 10X; Scale: 100μm. A: DAPI = Blue. B: HNA= Red. C: 
Merge = Purple. 
 
37 
 
 
FIGURE 19: KO+hUCBSCs chimeric eyes. The image represents the ‘lens-like structure’. 
Objective = 10X; Scale: 100μm. A: DAPI = Blue. B: HNA= Red. C: Merge = Purple. 
 
 
FIGURE 20: KO+hiPSCs chimeric eyes. The image represents the ‘lens-like structure’. 
Objective = 10X; Scale: 100μm. A: DAPI = Blue. B: HNA= Red. C: Merge = Purple. 
 
  HNA staining did not dtetect any human cells in the chimeras, and our hypothesis that the 
subtle changes in retinal pattern between chimeras and KOs possibly due to the presence 
of human cells, could not be confirmed. The human cells may have been present but were 
unable to integrate into host, since the action of Pitx3 is quite late in the developemnt of 
the eye to provide a niche. Along with Pitx3, FoxE3 and Prox1 are also involved in lens 
differentiation, and may be the reason why an absence of lens was not observed, and their 
compensation did not provide a wide enough opening for the human cells to integrate and 
contribute to the development of the organism’s eyes. 
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3.4 IMMUNOHISTOCHEMISTRY TO DETECT RETINAL LAMINATION  
 The analysis of the changes in retinal lamination between KOs and chimeras, was the next 
step. This was done by performing immunohistochemistry using antibodies against 
different retinal cell types such as rods, ganglion cells, mamacrine cells, astrocytes etc, 
depicted in figures 21-24 below. The goal was to stain for diffterent cell types, visualize 
their lamination patterns and possibly find a difference between KOs and chimeras. 
Immunohistochemistry was performed according to the protocol mentioned in the 
methods. WT porcine cells were used as a positive control as a model of retinal lamination. 
To label rod photoreceptors in the retina, an antibody against visual arrestin was used to 
stain eye sections. Panels depicting WT porcine eyes, show clear arrestin-labeled rod 
photoreceptors near the retinal pigment epithelial layer (RPE), as shown in pannel A-D of 
figure 21. While no proper lamination pattern can be observed in the KOs, E-H, figure 21 
a clump of retinal cells in the ‘lens-like structure’ can be observed. Unfortunately, 
complementation with human cells did nothing to improve retinal lamination as seen in the 
arrestin staining in KO+hiPSCs, represented in pannels I-L of figure 21. However, the 
lamination for P2E2 KO+hUCBSCs seems to be similar to the WT, M-P, figure 21. This 
can be corroborated by the histological images, which depicted that P2E2 KO+hUCBSCs 
had a thick, well formed retina (pannel R, figure 15).  
  Similarly, Glial fibrilary acidic protein (GFAP), stains astrocytes present in the ganglion 
cell layer (GCL) of the retina(figure 22). AP2 alpha, stains cells in the GCL and amacrine 
cells in inner plexiform layer (IPL), as portrayed in figure 23. Islet1 antibody labels 
horizontal, amacrine, bipolar and ganglion cells of the retina. Layers of cells in the GCL, 
IPL and INL (inner nuclear layer) can be observed in figure 24. A lamination pattern, 
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similar to  the lamination pattern for arrestin was observed for all the above mentioned 
antibodies.  
 
FIGURE 21: IHC for Arrestin on porcine and chimeric eyes. Arrestin labels rod 
photoreceptors in the retina, that are present right after the RPE. A-D: WT P3E12 porcine 
eyes. E-H: KO P4E2 porcine eyes. I-L: KO+hiPSCs chimeric porcine eyes. M-P: 
KO+hUCBSC chimeric eyes. A: merged image of control, B: Merge, C: Arrestin = Green 
and D: DAPI = Blue. The thin arrows depict arrestin positive rod photoreceptors. The thick 
arrows represent retinal orientation. The RPE is present at the base of the arrow, while the 
GCL is towards the head of the arrow. Objective: 20X. Scale: 100μm. 
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FIGURE 22: IHC for GFAP on porcine and chimeric eyes. GFAP labels astrocytes in the 
GCL in the retina. A-D: WT P3E12 porcine eyes. E-H: KO P4E2 porcine eyes. I-L: 
KO+hiPSCs P1E2 chimeric porcine eyes. M-P: KO+hUCBSC P2E2 chimeric eyes. A: 
merged image of control, B: Merge, C: GFAP = Green and D: DAPI = Blue. The thin 
arrows depict GFAP positive astrocytes. The thick arrows represent retinal orientation. The 
RPE is present at the base of the arrow, while the GCL is towards the head of the arrow. 
Objective: 20X. Scale: 100μm. 
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FIGURE 23: IHC for AP2alpha on porcine and chimeric eyes. AP2alpha labels cells in 
the GCL and amacrine cells in the IPL, in the retina. A-D: WT P3E12 porcine eyes. E-H: 
KO P4E2 porcine eyes. I-L: KO+hiPSCs P1E2 chimeric porcine eyes. M-P: 
KO+hUCBSC P2E2 chimeric eyes. A: merged image of control, B: Merge, C: AP2alpha 
= Green and D: DAPI = Blue. The thin arrows depict AP2alpha positive cells in the GCL, 
while the arrow heads indicate the amacrine cells in the IPL. The thick arrows represent 
retinal orientation. The RPE is present at the base of the arrow, while the GCL is towards 
the head of the arrow. Objective: 20X. Scale: 100μm. 
42 
 
 
 
FIGURE 24: IHC for Islet1 on porcine and chimeric eyes. Islet1 labels cells in the GCL, 
IPL and INL, such as horizontal, amacrine, bipolar and ganglionic cells of the retina. A-D: 
WT P3E12 porcine eyes. E-H: KO P4E2 porcine eyes. I-L: KO+hiPSCs P1E2 chimeric 
porcine eyes. M-P: KO+hUCBSC P2E2 chimeric eyes. A: merged image of control, B: 
Merge, C:Islet1 = Green and D: DAPI = Blue. The thin arrows depict Islet1 positive cells 
in the GCL and IPL, while the arrow heads indicate Islet1 positive cells in the INL, such 
as bipolar and horizontal. The thick arrows represent retinal orientation. The RPE is present 
at the base of the arrow, while the GCL is towards the head of the arrow. Objective: 20X. 
Scale: 100μm. 
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 Thus, immunohistochemistry using antibodies against specific retinal cells, permitted the 
visualization of different cells in the different retinal layers. This has provided proof that 
retinal lamination exists in all the porcine eyes, including the KOs. This, also confirms the 
hypothesis that the purple cells in the ‘lens-like structure’ from the H&E data are retinal 
cells, and that the retina has failed to disassociate from the lens and has folded together 
with the lens, due to lack of Pitx3 expression. Although, no difference in lamination was 
found, some papers have reported that loss of retinal cells in Pitx3 KO animals (Shi et al., 
2005).  Thus, the next step would be to ascertain a qualitative if not a quantitative difference 
between the four groups.  
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DISCUSSION AND FUTURE DIRECTIONS 
  The main purpose of this study was to demonstrate the possibility of using blastocyst 
complementation as a technique to generate human cells and organs in organogenesis-
disabled animal models. Previous studies have indicated that donor cell derived organs 
have been created in organogenesis disabled animals by genetically manipulating a gene 
of interest. Complementation studies have thus far been attempted in mice, rats and pigs 
(Chen et al., 1993; Kobayashi et al., 2010; Liégeois et al., 1996; Matsunari et al., 2013; 
Usui et al., 2012). The use of human cells for complementation with porcine blastocysts 
has not been previously reported. In the current study, the possibility of human lens 
generation using Pitx3 KO blastocysts, by complementation with hiPSCs and hUCBSCs, 
has been investigated.  
  Over the years, many studies have implicated Pitx3 in the involvement of lens 
differentiation (Semina et al., 1997, 1998, 2000), not just in mice and rats, but also in 
zebrafish and xenopus (Khosrowshahian et al., 2005; Shi et al., 2005). Pitx3 is also 
involved in SN DA neuron development in the mesDA system (Hwang et al., 2003; 
Maxwell et al., 2005; Nunes et al., 2003; Smidt et al., 2004a, 2004b), and its connection to 
Parkinson’s disease make it an important gene to study (Le et al., 2011). Many 
transplantation studies have been evaluated, including the transplantation of human 
embryonic dopaminergic neurons into patients with PD (Björklund and Lindvall, 2000). 
However, recovery was reported to be incomplete. Studies have also been done to improve 
the function of these dopaminergic neurons after transplantation, by treatment with 
taurourdeoxycholic acid with transplantation studies performed in rats (Duan et al., 2002). 
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Thus, a way to produce donor-derived organs for transplantation in the central nervous 
system is important. 
  Previously, our lab has used human pluripotent stem cells, to confirm that a 
complementation study using porcine blastocysts is possible (Swaminathan P. 2014). The 
human pluripotent stem cells were injected into porcine parthenogenic morulae and 
chimeric embryos were generated, where human cells were observed in the ICM of the 
blastocysts as well as in liver tissue after 32 days in gestation. Based on that study, Pitx3 
KO blastocysts were generated, and some of these KO blastocysts received hiPSCs and 
hUCBSCs that were transferred to a surrogate, thus chimeric embryos were generated, by 
Carlson et.al at Recombinetics.  
 The phenotypic analysis of porcine and human-porcine chimeric eyes provided us with an 
‘open eye index’. The WT had an index of 100% since nothing was lacking, and as the 
positive control the eyelid phenotype was expected to be normal. The KO however, lacking 
Pitx3 function, placed at 0% and was the negative control. Thus, by calculating the eye 
index for the chimeras, our aim was to find out where they placed. If they had a higher 
index and placed in the range of the WTs, they were deemed to have an improvement. 
According to our analysis, chimeric embryos P2E1, P2E3, P2E4, P2E6, P2E8 and P1E2 
were deemed to have a slightly better phenotype than the KOs. 
 Thus, next we attempted to corroborate the phenotypic result with morphological analysis, 
by staining tissue sections with H&E. These sections provided proof of the presence of a 
‘lens-like structure’ in the center of the eye and unfortunately, our study did not recapitulate 
the lack of lens phenotype seen in aphakia mice (Semina et al., 2000). The WT sections all 
presented with a thick purple retina, while most of the KOs and chimeras had a thin retina, 
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with purple cells mixed with the pink lens cells. Some KO+hUCBSC chimeras such as, 
P2E2, P2E6 and P2E8 had a thick laminated retina. Thus, the phenotypic analysis may 
have corroborated for these three, and possibility of improvement in eye development due 
to the presence of human cells was considered. Thus, all eyes were stained against HNA, 
to detect human cells. Unfortunately, no human cells were detected in any of the eyes.  
Pitx3 gene expression may be too late in eye development for the human cells to have a 
niche to integrate into the host and contribute to lens formation. Perhaps, other genes such 
as FoxE3 and Prox1 have provided enough expression for lens development that the human 
cells were not provided with an opportunity to contribute (Mochizuki and Masai, 2014; 
Ogino et al., 2012). The thick retinal lamination was also detected in a few of the KOs as 
well such as, P4E6, P4E8 and P5E1. Since the KOs were produced from a single clone, 
this difference in morphology remains unexplained.   
 Another factor that was noticed from H&E stains were the purple cells in the ‘lens-like 
structure’. No study has previously reported the clumping of the retina, thus to characterize 
the cells, they were stained with antibodies against retinal cells. Immunohistochemistry, 
provided proof that they were in-fact retinal cells, mixed in with the lens. On close analysis, 
it can be noted that some areas of the retina (especially in P2E2 and P2E8) have good 
structural lamination, while others do not. Since the retina and lens develop from the head 
ectoderm and later separate out into lens placode and optic cup (Ogino et al., 2012), and 
we observe a lack of separation in the KOs and chimeras, we report that Pitx3 may be 
highly involved in the regulation of this separation and providing us with the possibility of 
another function for Pitx3 in eye development. Studies have also reported the loss of certain 
types of retinal cells in Pitx3 KO animals (Khosrowshahian et al., 2005). Thus, the next 
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step is to analyze the images of all sections labeled with retinal markers. The possibility of 
a qualitative or a quantitative difference existing between the four groups, and the 
possibility of recapitulating it in porcine models is currently under investigation.  
 From our experiments we desired to provide evidence that connected the ‘closed/opaque’ 
and ‘open/transparent’ eyelid phenotype with the lens morphology, which in turn 
connected the retinal phenotype. We hoped to see that an eye with opaque eyelid, exhibited 
a lack of lens phenotype or irregular lens formation, as well as degradation of retinal 
lamination. We also hoped to determine that, complementation with human pluripotent 
cells had ameliorated the KO phenotype, by rescuing the lens development, or the retinal 
lamination. However, a clean cut path connecting each of them, was not visible from our 
studies (refer table figure 25). Our results suggest that Pitx3 expression may be too late in 
development to provide an ideal niche for human pluripotent cell integration, was reached. 
Another point of consideration are the hiPSCs, where the pluripotent cells being injected 
may not be ‘naïve’ enough to efficiently contribute to the complementation. Although, our 
results do not provide a positive outcome of the lens, some human cells have been detected 
in our study of the DA system. The table below shows a summary of these results. Thus, 
the study has laid the ground work for future experiments. It is important to understand 
blastocyst complementation in pigs further, by performing complementation studies using 
porcine stem cells, before moving forward with complementation with human stem cells, 
which is the next approach of our future experiments, along with investigating the 
possibility of manipulating transcription factors that are expressed much earlier in 
development such as, Lmx1b along with Pitx3. 
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FIGURE 25: A summary of results. ‘+’ indicates presence, while ‘-’indicates absence. 
While HNA positive cells were observed in the SN none were seen in the lens, with only 
P2E4 indicating a positive for retina, eyelid and human cells in the SN, while the rest do 
not show the same level of correlation. 
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